Related Experiment Video
Updated: Mar 9, 2026

08:05
Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
Published on: March 19, 2018
20.8K
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Mireia Lopez-Siles1, Sylvia H Duncan2, L Jesús Garcia-Gil1
1Laboratori de Microbiologia Molecular, Departament de Biologia, Universitat de Girona, Girona, Spain.
The ISME Journal
|January 4, 2017
Summary
Faecalibacterium prausnitzii is a key gut bacterium. Monitoring its levels may help diagnose and manage gut disorders like ulcerative colitis and Crohn's disease.
Area of Science:
- Microbiome Research
- Gut Health
- Bacterial Phylogeny
Background:
- Faecalibacterium prausnitzii is a dominant gut bacterium with significant health implications.
- Factors influencing its abundance and its diverse phylogenetic groups are not fully understood.
- Reduced F. prausnitzii levels are observed in various intestinal disorders.
Purpose of the Study:
- To review the phylogeny, ecophysiology, and diversity of F. prausnitzii.
- To explore strategies for modulating F. prausnitzii abundance in the gut.
- To discuss the potential of F. prausnitzii as a diagnostic and prognostic biomarker for gut diseases.
Main Methods:
- Literature review and synthesis of existing research on F. prausnitzii.
- Analysis of phylogenetic data to understand F. prausnitzii diversity.
- Discussion of studies on factors affecting F. prausnitzii abundance and its clinical applications.
Main Results:
- Identified at least two distinct F. prausnitzii phylogroups with differential distribution in health and disease.
- Highlighted the challenge in identifying factors crucial for maintaining F. prausnitzii abundance.
- Confirmed reduced F. prausnitzii levels in multiple intestinal conditions.
Conclusions:
- F. prausnitzii exhibits significant phylogenetic diversity, with potential for undiscovered species and phylogroups.
- Modulating F. prausnitzii abundance is a potential therapeutic strategy.
- F. prausnitzii shows promise as a biomarker for diagnosing and predicting gut diseases, particularly ulcerative colitis and Crohn's disease.
More Related Videos
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
1.0K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
733
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
733

